Skip to main content
. 2019 Oct 7;9:14394. doi: 10.1038/s41598-019-50840-7

Figure 6.

Figure 6

Viability of NSCLC cells after single or combined treatment (72 h) with (A,B) VER-155008 (VER) and cisplatin (CDDP); (C) JG-98 and CDDP; (DG) VER and bortezomib (BTZ); and (H,I) JG-98 and BTZ. Cell viability was measured using MTS assay. Results are expressed in relation to the untreated control (mean ± SD, n ≥ 3, each in triplicate). (G,J) Detection of dead cells following 72 h treatment of cells with VER (G), JG-98 (J), BTZ or both drugs. In (G) results of propidium iodide (PI) uptake test show mean values ± SD (n = 4, each in duplicate). In (J) results of lactate dehydrogenase (LDH) release assay are shown (mean values ± SD, n ≥ 4, each in duplicate). Statistical significance was determined using two-tailed t-test (AC) or one-way analysis of variance (ANOVA) with Scheffe’s (DG) or Duncan’s (H,I) adjustment for pairwise comparisons.